EKSO Q3 2024 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M-10.4% YoY

Gross Profit

$2M53.5% margin

Operating Income

-$3M-63.9% margin

Net Income

-$2M-50.2% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-16.6%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$470,000

Balance Sheet

Total Assets

$29M

Total Liabilities

$14M

Stockholders' Equity

$15M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-10.4%
Gross Profit	$2M	$2M	-10.1%
Operating Income	-$3M	-$3M	+10.0%
Net Income	-$2M	-$3M	+38.4%

Revenue Segments

Product

$3M76%

Service

$691,00017%

Product and Service, Other

$195,0005%

Subscription

$123,0003%

Geographic Segments

Americas

$2M23%

UNITED STATES

$2M23%

EMEA

$2M21%

FRANCE

$1M13%

EMEA Other

$537,0007%

Asia Pacific

$517,0006%

APAC Other

$303,0004%

HONG KONG

$214,0003%

POLAND

$113,0001%

Americas Other

$18,0000%